Insider Trading activities of Phasebio Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Phasebio Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Phasebio Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Phasebio Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is PHAS. The reporting company's CIK number is 1169245.
The total value of stock buying since 2005 is $15,149,156.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Phasebio Pharmaceuticals Inc (PHAS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 13,500 $49,156 0 $0 0 $0
2018-10 3,020,000 $15,100,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Phasebio Pharmaceuticals Inc insiders (PHAS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-11 York Michael (VP, Corporate Development) Buy 1,500 3.88 5,820
2018-12-10 Mow Jonathan P (Chief Executive Officer) Buy 800 3.85 3,080
2018-12-07 Sharp John P (CFO and Secretary) Buy 5,000 3.84 19,200
2018-12-07 Mow Jonathan P (Chief Executive Officer) Buy 2,200 3.88 8,536
2018-12-04 Thorp Clay (Director) Buy 4,000 3.13 12,520
2018-10-22 Crumpler John (10% Owner) Buy 300,000 5.00 1,500,000
2018-10-22 Zeneca, Inc. (10% Owner) Buy 600,000 5.00 3,000,000
2018-10-22 Thorp Clay (Director) Buy 300,000 5.00 1,500,000
2018-10-22 Viswanathan Ravi (10% Owner) Buy 1,800,000 5.00 9,000,000
2018-10-22 Tufts Linda (Director) Buy 20,000 5.00 100,000

Insider trading activities including stock purchases, stock sales, and option exercises of PHAS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Phasebio Pharmaceuticals Inc (symbol PHAS, CIK number 1169245) see the Securities and Exchange Commission (SEC) website.